Back

Prognostic value of excess apolipoprotein B in coronayr artery disease: a pooled analysis of nationwide cohorts

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Comorbidities and prognosis in chronic coronary syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Xiaozhao Lu

Guangzhou (China)

4 More presentations in this session

Presentation thumbnail
Implementation of new antithrombotic treatment strategies and outcome improvements in patients with myocardial infarction and atrial fibrillation over 20 years: a nationwide cohort study
Doctor C. Losciale (Nykoping, SE)
Abstract Slides Video
Presentation thumbnail
Prevalence of elevated lipoprotein(a) in premature ASCVD patients and its association with major adverse cardiovascular events: analysis of a large US electronic health record database
Doctor N. Shah (Cary, US)
Abstract Slides Video
Presentation thumbnail
PROGNosis in Obstructive Sleep Apnea after Myocardial Infarction - the PROGNOSA-MI study
Mr M. Olszowka (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
Regional and demographic variations in diabetes mellitus and myocardial infarction mortality among US adults: a retrospective observational analysis from 1999-2023
Doctor C. Ranasinghe (Birmingham, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Comorbidities and prognosis in chronic coronary syndromes
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Association of lipoprotein(a) with coronary plaque progression in patients with acute coronary syndrome assessed by optical coherence tomography
thumbnail
Congress Presentation
Prognostic predictive value of circulating angiopoietin-like protein 3 in patients with chronic coronary syndrome
thumbnail
Congress Presentation
Icosapent ethyl reduces cardiovascular risk across apolipoprotein b and fasting triglyceride rich lipoprotein levels

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources